Top of Page
Skip main navigation
2019 NOVA Law Review Symposium banner with blue lettering on a gray background

 First Do No Harm: A Patient-Driven Approach to Navigating the Health Law, Intellectual Property, and Technology Maze

Friday, October 11, 2019  |  9:00 a.m. - 5:00 p.m. 

NSU Shepard Broad College of Law  |  Panza Maurer Law Library, 3rd Floor
CLE Credit and Certification Credit information

The Florida Bar CLE Credits

General 6.0
Ethics 2.0
Technology 2.0

The Florida Bar Certification Credits

Health Law 6.0
Intellectual Property Law 2.0

Two of the fastest growing areas in the modern economy are health care and technology. In the race to provide innovations in health care and technology, however, the patient and caregiver are often left out of the conversation. Consequently, some technologies, intellectual property rules, health care options, and health policy decisions are replete with unintended consequences.

The Symposium presents an opportunity for academics, practitioners, health care providers, and students in a variety of legal, business, and technology fields to exchange ideas and explore emerging issues. Interdisciplinary presentations are encouraged.


Speakers (subject to change)


Danna Khawam
Nova Law Review | Editor-in-Chief Vol. 44

Portrait of a smiling woman with bookshelves lined with encyclopedias in the background Kathy Cerminara
NSU Shepard Broad College of Law
Professor of Law



What Would a Medical Data Information Commons Look Like, and how Would it Be Governed?

gross.jpg Marielle S. Gross, MD, MBE
Hecht-Levi Fellow, Johns Hopkins Berman Institute of Bioethics
About Me, But Not for Me: The Ethical-Legal Gray Zone of Deidentified Health Data

Melissa M. Goldstein, J.D.
Associate Professor Department of Health Policy and Management, Milken Institute School of Public Health, George Washington University
Redefining Sensitive Data


Sharon Bassan, Ph.D.
Jaharis Faculty Fellow in Health Law and Intellectual Property at the DePaul University College of Law
Active Users? The Roles of Data Subjects in Managing Their Data


Marilyn Uzdavines 
NSU Shepard Broad College of Law
Professor of Law

Patient Protection or Caveat Emptor? (Some) Risks Posed By High-Tech, Data-Driven Medicine


Yaniv Heled, J.S.D., LL.M., LL.B.
Associate Professor of Law of Law; Co-Director, Center for Intellectual Property
Georgia State University College of Law
Competition in Biological Pharmaceutical Markets


Bethany Corbin, J.D., LL.M.
Director of Master of Studies in Law, Wake Forest University
FemTech: Societal, Ethical, and Privacy Implications of Digitizing the Female Body


Jennifer Wagner, J.D., Ph.D.
Geisinger Center for Translational Bioethics and Health Care Policy
Precision Medicine and the FTC


Robert Kain
Shareholder, Kain Speilman PA

Will Human Gene Editing Improve Health, Promote Eugenics, Or Both?


Myrisha Lewis, J.D.
William & Mary Law School
The Coming Age of Gene Editing: Medical Promise, Regulation, and the Revival of Decades of Debate


Seema Mohapatra, J.D. MPH
Indiana University Robert H. McKinney Schooll of Law
Regulating Human Germline Editing


Samantha Zyontz, Ph.D.
Research Fellow, Intellectual Property, Stanford Law School
Running with (CRISPR) Scissors: Tool Adoption and Team Assembly


Jonas Monast, J.D.
C. Boyden Gray Distinguished Fellow, Assistant Professor and Director of the Center on Climate, Energy, Environment & Economics
University of North Carolina School of Law
Governing Extinction in the Era of Gene Editing


Kathy Cerminara
NSU Shepard Broad College of Law
Professor of Law

Question & Answer Panel


Danna Khawam
Nova Law Review | Editor-in-Chief Vol. 44
Question & Answer Session


Robert Scheppske
Nova Law Review | Goodwin Alumni Editor
Question & Answer Session

A symposium issue based on the presentations at the conference will be published by the Nova Law Review.

 Back to Events

Return to top of page